Cargando…

Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review

BACKGROUND: The duration of viable viral shedding is important to be defined in regards of viral transmission in SARS-CoV-2 infection with the backdrop of the current worldwide effort for revising isolation polices and establishing the duration of infectiousness. METHODS: In this review we searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Qutub, Mohammed, Aldabbagh, Yasser, Mehdawi, Fahtima, Alraddadi, Abdullah, Alhomsy, Mohanna, Alnahdi, Abdulaziz, Fakeeh, Majed, Maghrabi, Abdullah, Alwagdani, Meshari, Bahabri, Nezar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of British Infection Association. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848577/
https://www.ncbi.nlm.nih.gov/pubmed/35190799
http://dx.doi.org/10.1016/j.clinpr.2022.100140
_version_ 1784652280355618816
author Qutub, Mohammed
Aldabbagh, Yasser
Mehdawi, Fahtima
Alraddadi, Abdullah
Alhomsy, Mohanna
Alnahdi, Abdulaziz
Fakeeh, Majed
Maghrabi, Abdullah
Alwagdani, Meshari
Bahabri, Nezar
author_facet Qutub, Mohammed
Aldabbagh, Yasser
Mehdawi, Fahtima
Alraddadi, Abdullah
Alhomsy, Mohanna
Alnahdi, Abdulaziz
Fakeeh, Majed
Maghrabi, Abdullah
Alwagdani, Meshari
Bahabri, Nezar
author_sort Qutub, Mohammed
collection PubMed
description BACKGROUND: The duration of viable viral shedding is important to be defined in regards of viral transmission in SARS-CoV-2 infection with the backdrop of the current worldwide effort for revising isolation polices and establishing the duration of infectiousness. METHODS: In this review we searched databases including Medline and google scholar for research articles published between January 2020 and January 2022. We included case reports, case series, cross sectional, cohort, and randomized control trials that reported the duration of shedding of viable SARS-CoV-2 virus. After evaluating the criteria for inclusion, 32 articles (2721 patients) were included. RESULT: This review showed that the median for the last day of successful viral isolation was 11 (8.5–14.5 95% CI) , 20 (9.0–57.5 95 %CI), 20 (9.0–103 95 %CI) for the general population, critical patients and immunocompromised individuals, respectively, with significant association between prolonged viral shedding, disease severity (P-Value 0.024) and immunosuppressive status (P-Value 0.023). The corresponding higher cutoff of CTv to culturable virus ranged between 26.25 and 34.00 (95% confidence interval) with median of 30.5, and higher values were observed when critical (25.0–37.37 95 %CI) and immunocompromised patients (20.0–37.82 95 %CI) have been excluded, this deviation did not represent a statistical significance (P-Value 0.997 and 0.888) respectively. CONCLUSION: Our review highlights that repeating SARS-CoV-2 viral RNA test solely in recovering patients has no importance in determining infectivity and emphasizes the individualization of de-isolation decisions based on the host factors and a combined symptom and testing-based approaches with the later benefiting most of correlation with recently introduced rapid antigen test. Our finding in the review also opposes the most recent CDC Guidance on shortening isolation duration in term of the last days of viable transmissible virus, therefore caution should be considered when revising such protocols.
format Online
Article
Text
id pubmed-8848577
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd on behalf of British Infection Association.
record_format MEDLINE/PubMed
spelling pubmed-88485772022-02-16 Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review Qutub, Mohammed Aldabbagh, Yasser Mehdawi, Fahtima Alraddadi, Abdullah Alhomsy, Mohanna Alnahdi, Abdulaziz Fakeeh, Majed Maghrabi, Abdullah Alwagdani, Meshari Bahabri, Nezar Clin Infect Pract Practical Clinical Reviews BACKGROUND: The duration of viable viral shedding is important to be defined in regards of viral transmission in SARS-CoV-2 infection with the backdrop of the current worldwide effort for revising isolation polices and establishing the duration of infectiousness. METHODS: In this review we searched databases including Medline and google scholar for research articles published between January 2020 and January 2022. We included case reports, case series, cross sectional, cohort, and randomized control trials that reported the duration of shedding of viable SARS-CoV-2 virus. After evaluating the criteria for inclusion, 32 articles (2721 patients) were included. RESULT: This review showed that the median for the last day of successful viral isolation was 11 (8.5–14.5 95% CI) , 20 (9.0–57.5 95 %CI), 20 (9.0–103 95 %CI) for the general population, critical patients and immunocompromised individuals, respectively, with significant association between prolonged viral shedding, disease severity (P-Value 0.024) and immunosuppressive status (P-Value 0.023). The corresponding higher cutoff of CTv to culturable virus ranged between 26.25 and 34.00 (95% confidence interval) with median of 30.5, and higher values were observed when critical (25.0–37.37 95 %CI) and immunocompromised patients (20.0–37.82 95 %CI) have been excluded, this deviation did not represent a statistical significance (P-Value 0.997 and 0.888) respectively. CONCLUSION: Our review highlights that repeating SARS-CoV-2 viral RNA test solely in recovering patients has no importance in determining infectivity and emphasizes the individualization of de-isolation decisions based on the host factors and a combined symptom and testing-based approaches with the later benefiting most of correlation with recently introduced rapid antigen test. Our finding in the review also opposes the most recent CDC Guidance on shortening isolation duration in term of the last days of viable transmissible virus, therefore caution should be considered when revising such protocols. The Authors. Published by Elsevier Ltd on behalf of British Infection Association. 2022-01 2022-02-16 /pmc/articles/PMC8848577/ /pubmed/35190799 http://dx.doi.org/10.1016/j.clinpr.2022.100140 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Practical Clinical Reviews
Qutub, Mohammed
Aldabbagh, Yasser
Mehdawi, Fahtima
Alraddadi, Abdullah
Alhomsy, Mohanna
Alnahdi, Abdulaziz
Fakeeh, Majed
Maghrabi, Abdullah
Alwagdani, Meshari
Bahabri, Nezar
Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review
title Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review
title_full Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review
title_fullStr Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review
title_full_unstemmed Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review
title_short Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review
title_sort duration of viable sars-cov-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review
topic Practical Clinical Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848577/
https://www.ncbi.nlm.nih.gov/pubmed/35190799
http://dx.doi.org/10.1016/j.clinpr.2022.100140
work_keys_str_mv AT qutubmohammed durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT aldabbaghyasser durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT mehdawifahtima durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT alraddadiabdullah durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT alhomsymohanna durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT alnahdiabdulaziz durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT fakeehmajed durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT maghrabiabdullah durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT alwagdanimeshari durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview
AT bahabrinezar durationofviablesarscov2sheddingfromrespiratorytractindifferenthumanhostsanditsimpactonisolationdiscontinuationpolicesrevisionanarrativereview